Cargando…
Celastrol-conjugated chitosan oligosaccharide for the treatment of pancreatic cancer
Celastrol is a promising antitumor drug candidate, but the poor water solubility and cytotoxicity limit its clinical application. Herein, we synthesized a Celastrol (Cel)-chitosan oligosaccharide (CSO) conjugate (Cel-CSO) for drug delivery. Celastrol was conjugated to a CSO backbone via amide bond f...
Autores principales: | Zeng, Xiaohu, Zhu, Xin, Tian, Qikang, Tan, Xiaoke, Sun, Ning, Yan, Min, Zhao, Junwei, Wu, Xiangxiang, Li, Ruiqin, Zhang, Zhenqiang, Zeng, Huahui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725862/ https://www.ncbi.nlm.nih.gov/pubmed/34964425 http://dx.doi.org/10.1080/10717544.2021.2018521 |
Ejemplares similares
-
In vivo antitumor effects of carboxymethyl chitosan-conjugated triptolide after oral administration
por: Zeng, Huahui, et al.
Publicado: (2020) -
Novel Carboxylated Chitosan-Based Triptolide Conjugate for the Treatment of Rheumatoid Arthritis
por: Zhang, Lan, et al.
Publicado: (2020) -
TP-CSO: A Triptolide Prodrug for Pancreatic Cancer Treatment
por: Wang, Xinlong, et al.
Publicado: (2022) -
A mitochondria-targeted nano-platform for pancreatic cancer therapy
por: Tan, Xiaoke, et al.
Publicado: (2022) -
The Effect of Triptolide Combined With Crocin on Arthritis in Mice: From Side Effect Attenuation to Therapy
por: Yan, Min, et al.
Publicado: (2022)